饮酒对绝经后妇女雌激素的影响
E S Ginsburg1, N K Mello, J H Mendelson
1Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA 02115, USA.
JAMA
|December 4, 1996
概括
适度饮酒会显著增加使用雌激素替代疗法 (ERT) 的绝经后妇女的雌激素水平. 这种相互作用可能会带来健康风险,需要进一步调查.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 生殖健康 生殖健康
背景情况:
- 绝经后的女性经常使用激素替代疗法 (HRT) 来治疗症状.
- 雌激素替代疗法 (ERT) 是一种常见的HRT形式.
- 酒精和ERT之间的相互作用尚未得到充分理解.
研究的目的:
- 研究适度饮酒对循环中的雌激素水平的影响.
- 为了比较ERT后绝经后妇女的这些影响与非ERT后妇女的这些影响.
主要方法:
- 进行了一项随机,双盲,安慰剂控制的交叉研究.
- 十二名接受ERT的绝经后妇女和12名不接受ERT的妇女参与了这项研究.
- 参与者在不同的日子里饮用了酒精 (0.7g/kg) 和安慰剂.
主要成果:
- 在接受ERT的女性中,酒精摄入导致雌激醇增加3倍,持续5小时.
- 在ERT组中,雌激素水平从297增加到973 pmol/L.
- 在不接受ERT的女性中,没有观察到雌激醇的显著变化.
- 在酒精和安慰剂后,在ERT组中雌激素水平下降.
- 血液中酒精含量在各组之间是相似的.
结论:
- 急性酒精摄入可以显著提高在ERT的妇女循环中的雌激素水平.
- 这些升高可以达到比治疗目标高300%的水平.
- 需要进一步的研究来评估酒精与ERT相互作用的健康风险和益处.
相关概念视频
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...


